Johnson & Johnson Consumer France S.A.S. has completed its acquisition of Biapharm SAS. The transaction was announced on August 27, 2004. The terms were not disclosed.

Biapharm SAS, headquartered in Houdan, France, is a producer and marketer of skin care products centred on the leading brand Biafine, the well-known skin-healing brand on the French market. The group is headed by holding company Biapharm SAS which, in turn, controls 100 per cent of Laboratoire Medix (the group's main operating company).

Other products marketed by Medix include complementary skin care brands Aloplastine and Effidia, a scab-healing product.